Search

AusCann to trial cannabinoids on spinal cord injuries

Cannabinoid-derived therapeutic products developer, AusCann Group, announced that it has commenced the design phase for a clinical discovery trial to evaluate the company’s proprietary cannabinoid-based formulations in people with Spinal Cord Injury.